CG MedTech Co.,Ltd. (KOSDAQ:056090)

CG MedTech Statistics

Total Valuation

CG MedTech has a market cap or net worth of KRW 139.81 billion. The enterprise value is 140.00 billion.

Market Cap	139.81B
Enterprise Value	140.00B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

CG MedTech has 103.26 million shares outstanding. The number of shares has increased by 35.47% in one year.

Current Share Class	103.26M
Shares Outstanding	103.26M
Shares Change (YoY)	+35.47%
Shares Change (QoQ)	-0.79%
Owned by Insiders (%)	0.26%
Owned by Institutions (%)	n/a
Float	61.12M

Valuation Ratios

The trailing PE ratio is 21.10.

PE Ratio	21.10
Forward PE	n/a
PS Ratio	2.88
PB Ratio	1.47
P/TBV Ratio	1.68
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.13, with an EV/FCF ratio of -10.71.

EV / Earnings	21.20
EV / Sales	2.89
EV / EBITDA	23.13
EV / EBIT	40.61
EV / FCF	-10.71

Financial Position

The company has a current ratio of 2.55, with a Debt / Equity ratio of 0.16.

Current Ratio	2.55
Quick Ratio	1.40
Debt / Equity	0.16
Debt / EBITDA	2.47
Debt / FCF	-1.14
Interest Coverage	19.56

Financial Efficiency

Return on equity (ROE) is 7.25% and return on invested capital (ROIC) is 3.78%.

Return on Equity (ROE)	7.25%
Return on Assets (ROA)	1.85%
Return on Invested Capital (ROIC)	3.78%
Return on Capital Employed (ROCE)	3.14%
Weighted Average Cost of Capital (WACC)	3.49%
Revenue Per Employee	404.28M
Profits Per Employee	55.03M
Employee Count	120
Asset Turnover	0.42
Inventory Turnover	1.91

Taxes

Income Tax	-3.67B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +45.06% in the last 52 weeks. The beta is -0.09, so CG MedTech's price volatility has been lower than the market average.

Beta (5Y)	-0.09
52-Week Price Change	+45.06%
50-Day Moving Average	1,907.94
200-Day Moving Average	1,533.74
Relative Strength Index (RSI)	26.89
Average Volume (20 Days)	1,138,812

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CG MedTech had revenue of KRW 48.51 billion and earned 6.60 billion in profits. Earnings per share was 64.16.

Revenue	48.51B
Gross Profit	21.35B
Operating Income	3.45B
Pretax Income	2.94B
Net Income	6.60B
EBITDA	6.05B
EBIT	3.45B
Earnings Per Share (EPS)	64.16

Balance Sheet

The company has 14.96 billion in cash and 14.95 billion in debt, with a net cash position of 13.67 million or 0.13 per share.

Cash & Cash Equivalents	14.96B
Total Debt	14.95B
Net Cash	13.67M
Net Cash Per Share	0.13
Equity (Book Value)	94.87B
Book Value Per Share	924.08
Working Capital	25.37B

Cash Flow

In the last 12 months, operating cash flow was -1.06 billion and capital expenditures -12.01 billion, giving a free cash flow of -13.07 billion.

Operating Cash Flow	-1.06B
Capital Expenditures	-12.01B
Depreciation & Amortization	2.61B
Net Borrowing	7.29B
Free Cash Flow	-13.07B
FCF Per Share	-126.57

Margins

Gross margin is 44.00%, with operating and profit margins of 7.11% and 13.61%.

Gross Margin	44.00%
Operating Margin	7.11%
Pretax Margin	6.05%
Profit Margin	13.61%
EBITDA Margin	12.48%
EBIT Margin	7.11%
FCF Margin	n/a

Dividends & Yields

CG MedTech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-35.47%
Shareholder Yield	-35.47%
Earnings Yield	4.72%
FCF Yield	-9.35%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on August 5, 2022. It was a forward split with a ratio of 5.

Last Split Date	Aug 5, 2022
Split Type	Forward
Split Ratio	5

Scores

CG MedTech has an Altman Z-Score of 2.7 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.7
Piotroski F-Score	3